NCT07503418

Brief Summary

The goal of this randomized controlled trial is to evaluate the effectiveness of a multimodal Parkinson's disease-focused intervention on empathy levels and perceived theoretical-practical learning in third-year undergraduate nursing students. The main questions it aims to answer are:

  • Will students receiving the multimodal intervention demonstrate significantly higher levels of clinical empathy compared to those receiving standard simulation-based workshops?
  • Will the intervention significantly improve awareness of Parkinson's disease (PD) quality of life and the internalisation of the patient's lived experience? Researchers will compare the experimental group, which receives a multimodal approach including blended learning and a simulated home environment, to a control group receiving standard simulation workshops on physiological aging to see if the multimodal strategy offers superior outcomes in clinical awareness and empathy development. Participants will:
  • Attend a two-hour initial theoretical session regarding neurodegenerative disorders and nursing care.
  • Complete digital blended-learning micro-capsules covering PD pathophysiology and authentic patient testimonials (Experimental Group only).
  • Engage in high-fidelity physical simulation using GERT® suits to perform activities of daily living (e.g., dressing, eating, and walking) within either a recreated domestic environment or a standard classroom setting.
  • Participate in a structured debriefing session focused on reflective analysis of the emotional and functional impact of Parkinson's symptoms.
  • Complete validated self-administered instruments during pretest and posttest phases to measure empathy, satisfaction, and perception of learning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 31, 2026

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

March 25, 2026

Last Update Submit

March 25, 2026

Conditions

Keywords

EmpathyHigh Fidelity Simulation TrainingNursing Education ResearchParkinson DiseasePatient Simulation

Outcome Measures

Primary Outcomes (2)

  • Clinical empathy

    Clinical empathy will be measured by the Jefferson Scale of Physician Empathy (JSPE), validated into Spanish. It is made up of 20 items with scoring using a 7-points Likert scale (1 = strongly disagree, 7 = strongly agree). Ten of the 20 questions are valued negatively (and rectified positively in the subsequent analysis), in order to reduce the effect of acquiescence when responding. The range of possible scores goes from 20 to 140 points. The highest scores are associated with a greater degree of empathy.

    Day 1 (pretest) and Day 3 (post-test).

  • Awareness of Parkinson Disease quality of life

    It will measure by the Parkinson's Disease Questionnaire (PDQ-39), validated into Spanish. The PDQ-39 questionnaire assesses how often people with Parkinson's experience difficulties across 8 dimensions of daily living including relationships, social situations and communication. Although it is an instrument originally conceived as a patient-reported measure of health-related quality of life, students will asked to complete it by "taking the perspective" as if they were patients with the disease. Scores are expressed as a percentage, ranging from 0 (never have difficulty) to 100 (always have difficulty), with lower scores indicating better quality of life and higher scores indicating greater impairment.

    Day 1 (pretest) and Day 3 (post-test).

Secondary Outcomes (2)

  • Learning perception

    Day 3 (post-test).

  • Satisfaction with the simulations

    Day 3 (post-test).

Study Arms (2)

Experimental group

EXPERIMENTAL

Experimental Group (EG) will perform a multimodal simulation experience.

Other: Blended-learning capsulesOther: High-Fidelity Physical SimulationOther: Simulated Home Environment

Control Group

NO INTERVENTION

Control Group will participate in a standard workshop on physiological ageing using GERT® simulators.

Interventions

Digital learning modules covering PD pathophysiology and authentic patient testimonials through audiovisual pills co-developed with the "Santa Adela" Parkinson's Association

Experimental group

Using GERT® geriatric suits specifically configured to simulate PD symptoms.

Experimental group

The EG simulation workshop was delivered in a home-visit simulation room designed to resemble a domestic setting, furnished with household-style equipment and furniture

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Third-year undergraduate nursing students enrolled in Geriatric Nursing subject from a Faculty of Nursing of the University of Cadiz (Spain).

You may not qualify if:

  • Participants who do not wish to take part in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing

Algeciras, Cadiz, 11207, Spain

Location

Related Publications (16)

  • Ward J, Schaal M, Sullivan J, Bowen ME, Erdmann JB, Hojat M. Reliability and validity of the Jefferson Scale of Empathy in undergraduate nursing students. J Nurs Meas. 2009;17(1):73-88. doi: 10.1891/1061-3749.17.1.73.

    PMID: 19902660BACKGROUND
  • Wang Y, Wang C, Yang Z, Tang Y, Chen W, Zheng Y, Wei Z, Li H. Latent profile analysis of empathy ability and its relationship with professional quality of life among hospice nurses in China. BMC Nurs. 2024 Sep 16;23(1):658. doi: 10.1186/s12912-024-02299-9.

    PMID: 39285294BACKGROUND
  • Wang R, Raman A. Systematic literature review on the effects of blended learning in nursing education. Nurse Educ Pract. 2025 Jan;82:104238. doi: 10.1016/j.nepr.2024.104238. Epub 2024 Dec 16.

    PMID: 39700839BACKGROUND
  • Vangone I, Arrigoni C, Magon A, Conte G, Russo S, Belloni S, Stievano A, Alfes CM, Caruso R. The efficacy of high-fidelity simulation on knowledge and performance in undergraduate nursing students: An umbrella review of systematic reviews and meta-analysis. Nurse Educ Today. 2024 Aug;139:106231. doi: 10.1016/j.nedt.2024.106231. Epub 2024 Apr 30.

    PMID: 38701671BACKGROUND
  • van Munster M, Czabanowska K, Clemens T, Wieczorek E, Pedrosa D, Mestre TA, Stumpel J. Priorities in healthcare provision in Parkinson's disease from the perspective of Parkinson Nurses: A focus group study. Int J Nurs Stud Adv. 2024 Jun 12;7:100213. doi: 10.1016/j.ijnsa.2024.100213. eCollection 2024 Dec.

    PMID: 39161697BACKGROUND
  • Tosin MHS, Mecone CAC, Oliveira EFM, Tsui DS, Tan SB, Irene S, Oliveira BC, de Oliveira BGRB. Nursing and Parkinson's Disease: A Scoping Review of Worldwide Studies. Clin Nurs Res. 2022 Feb;31(2):230-238. doi: 10.1177/10547738211044047. Epub 2021 Sep 6.

    PMID: 34486425BACKGROUND
  • Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2.

    PMID: 33894193BACKGROUND
  • Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T. Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025 Mar 5;388:e080952. doi: 10.1136/bmj-2024-080952.

    PMID: 40044233BACKGROUND
  • Martinez-Martin P, Frades Payo B. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol. 1998 May;245 Suppl 1:S34-8. doi: 10.1007/pl00007737.

    PMID: 9617722BACKGROUND
  • Martinez-Arce A, Rodriguez-Almagro J, Velez-Velez E, Rodriguez-Gomez P, Tovar-Reinoso A, Hernandez-Martinez A. Validation of a short version of the high-fidelity simulation satisfaction scale in nursing students. BMC Nurs. 2023 Sep 28;22(1):344. doi: 10.1186/s12912-023-01515-2.

    PMID: 37770843BACKGROUND
  • Li YY, Au ML, Tong LK, Ng WI, Wang SC. High-fidelity simulation in undergraduate nursing education: A meta-analysis. Nurse Educ Today. 2022 Apr;111:105291. doi: 10.1016/j.nedt.2022.105291. Epub 2022 Feb 3.

    PMID: 35158134BACKGROUND
  • Levett-Jones T, Cant R, Lapkin S. A systematic review of the effectiveness of empathy education for undergraduate nursing students. Nurse Educ Today. 2019 Apr;75:80-94. doi: 10.1016/j.nedt.2019.01.006. Epub 2019 Jan 26.

    PMID: 30739841BACKGROUND
  • Hopewell S, Chan AW, Collins GS, Hrobjartsson A, Moher D, Schulz KF, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne D, Farmer A, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson D, Vohra S, White IR, Boutron I. CONSORT 2025 statement: Updated guideline for reporting randomised trials. PLoS Med. 2025 Apr 14;22(4):e1004587. doi: 10.1371/journal.pmed.1004587. eCollection 2025 Apr.

    PMID: 40228477BACKGROUND
  • Farres-Tarafa M, Roldan-Merino J, Lorenzo-Seva U, Hurtado-Pardos B, Biurrun-Garrido A, Molina-Raya L, Morera-Pomarede MJ, Bande D, Raurell-Torreda M, Casas I. Reliability and validity study of the Spanish adaptation of the "Educational Practices Questionnaire" (EPQ). PLoS One. 2020 Sep 17;15(9):e0239014. doi: 10.1371/journal.pone.0239014. eCollection 2020.

    PMID: 32941464BACKGROUND
  • Crooks S, Stark P, Carlisle S, McMullan J, Copeland S, Wong WYA, Blake D, Lyons E, Campbell N, Carter G, Wilson CB, Mitchell G. Evaluation of a co-designed Parkinson's awareness audio podcast for undergraduate nursing students in Northern Ireland. BMC Nurs. 2023 Oct 9;22(1):370. doi: 10.1186/s12912-023-01544-x.

    PMID: 37814245BACKGROUND
  • Baghaei A, Kim HS, Dolhun R, Sherzai D, Dashtipour K. Review of the Effects of Lifestyle Modification on Parkinson's Disease. Am J Lifestyle Med. 2025 Oct 3:15598276251384591. doi: 10.1177/15598276251384591. Online ahead of print.

    PMID: 41050191BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The study will be blinded during the randomization of participants, the evaluation of the simulations and the statistical analysis.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Collaborator investigator

Study Record Dates

First Submitted

March 25, 2026

First Posted

March 31, 2026

Study Start

February 1, 2025

Primary Completion

May 31, 2025

Study Completion

June 30, 2025

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The dataset compiled during the study, which has been appropriately processed to ensure the anonymity of the participants, will be made openly available when the study results are published.

Shared Documents
STUDY PROTOCOL

Locations